Jun Lu

7PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2026
GLUT6-facilitated noncanonical glucose metabolic rewiring enables resistance to targeted cancer therapy.

|Aug 30, 2025
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer.

Chao Zhou, Yuqing Liu, Hongyu Liu

|May 02, 2025
Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer.

Hongyu Liu, Chao Zhou, Jun Lu

|Dec 17, 2024
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China.

Hua Zhong, Jun Lu, Mengzhao Wang

|Nov 08, 2024
Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non-Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study.

Zhiqiang Gao, Jiajun Teng, Rong Qiao

|Aug 26, 2021
hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.

Changhui Li, Jiaqi Zhang, Xiaohua Yang

Pageof 2

Frequent Collaborators

5 joint publications

Baohui Han

3 joint publications

Liang Zhu

1 joint publications

Yuqing Lou

1 joint publications

Huimin Wang